ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016
Differential Sensitivity to Crizotinib: Does EML4-ALK Fusion Variant Matter?
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- SplitFusion enables ultrasensitive gene fusion detection and reveals fusion variant-associated tumor heterogeneity.Patterns (New York, N.Y.) · 2025Article
- Impact of EML4-ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non-small Cell Lung Cancer.Thoracic cancer · 2025Article
- [Histology, cytology and molecular diagnostics of lung cancer].Der Pathologe · 2019Review
- Article
- Stop fRETting the Target: Next-Generation RET Inhibitors Have Arrived.Cancer discovery · 2018Article
- Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2018Article
- Article
- Review
- Targeting ALK: Precision Medicine Takes on Drug Resistance.Cancer discovery · 2017Review
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
27458283What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.